Course (Pharmacokinetics for Pharmaceutical Scientists )
2020 - 2020
Universidad Autónoma de Madrid
Doctor of Medicine (MD)
University of Barcelona
Doctor of Philosophy - PhD (Translational Neuroscience)
La Paz University Hospital
Residency in Neurology
2009 - 2013
NIH Clinical Center
Course (Introduction to the Principles and Practice of Clinical Research)
2016 - 2017
University of California, Berkeley
Course (US Food and Drug Administration, Drug Development, Science and Health Policy)
2017 - 2017
Università degli Studi di Milano
M (Socrates-Erasmus Grant)
2006 - 2007
Universidad Pablo de Olavide
Masters in Neuroscience (Medicine)
2009 - 2010
Universidad Pablo de Olavide
Máster en Sueño: Medicina y Fisiología (Medicina)
2010 - 2011
Andrés Cruz Herranz's Skills
Clinical Trials
Terapia
Oratoria
Public Speaking
Epidemiology
Medical Education
Neurology
Teaching
Clinical Research
Medicina
Andrés Cruz Herranz's Summary
Andrés Cruz Herranz, based in Barcelona, CT, ES, is currently a Medical Director, Clinical Development at Prilenia, bringing experience from previous roles at Denali Therapeutics, Genentech, Frontiers and University of California, San Francisco. Andrés Cruz Herranz holds a 2020 - 2020 Course in Pharmacokinetics for Pharmaceutical Scientists @ University of California, San Francisco. With a robust skill set that includes Clinical Trials, Terapia, Oratoria, Public Speaking, Epidemiology and more, Andrés Cruz Herranz contributes valuable insights to the industry. Andrés Cruz Herranz has 1 email and 1 mobile phone number on RocketReach.